Cannabinoid CB1 Receptor Immunoreactivity in the Prefrontal Cortex: Comparison of Schizophrenia and Major Depressive Disorder

Stephen M Eggan, Samuel R Stoyak, Christopher D Verrico, David A Lewis
  • Neuropsychopharmacology, June 2010, Springer Science + Business Media
  • DOI: 10.1038/npp.2010.75

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1038/npp.2010.75

The following have contributed to this page: Dr Christopher D Verrico